Keros Therapeutics Inc — Cash Flow (NASDAQ:KROS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 36.89 M62.15 M70.06 M124.51 M160.87 M 180.81 M Cash from investing activities 294 K1.02 M1.24 M2.46 M1.93 M 1.71 M Cash from financing activities 296.04 M28.55 M120.31 M178.96 M391.82 M 75.7 M Free cash flow 36.6 M61.12 M68.82 M122.04 M158.94 M 179.1 M

Noticias

Keros Therapeutics suma exdirector financiero de Lyell a su consejo

Should Investors Buy, Sell or Hold KROS Stock Ahead of Q4 Earnings?

Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results?

SRPT Stock Up 8% on Positive Long-Term Data From Elevidys Study in DMD

Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside?

Is KROS' KER-065 the Next Breakthrough in DMD Space?

JANX Enters Global Oncology Collaboration With BMY, Stock Rises

Ionis' Dawnzera Gets EU Approval for Hereditary Angioedema

MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know

Novartis' Ianalumab Wins Breakthrough Therapy Tag for Sjogren's Disease

Axsome Therapeutics Begins Phase III Study on AXS-14 for Fibromyalgia

Will KROS Stock's Restructuring Efforts Reap Rewards for Investors?